Psychologists in Forest Park, IL Accepting Medicare
6 Psychologists found. Showing 1 - 6
 Dr. Paul Francis Driscoll, PH.D. Psychologist - Cognitive & Behavioral Medicare: Accepting Medicare Assignments Practice Location: 7442 Harrison St, Forest Park, IL 60130 Phone: 708-254-9365 |
 Gabriela I. Sierra, MA Psychologist - Mental Retardation & Developmental Disabilities Medicare: Not Enrolled in Medicare Practice Location: 828 Hannah Ave, Forest Park, IL 60130 Phone: 708-257-6074 |
Jessica H Kinkela, PHD Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 7227 Roosevelt Rd Apt 5, Forest Park, IL 60130 Phone: 740-707-5487 |
Dr. John Edward Noto Jr., PH.D. Psychologist - Adult Development & Aging Medicare: Accepting Medicare Assignments Practice Location: 8311 Roosevelt Rd, Suite 100, Forest Park, IL 60130 Phone: 708-366-5555 |
Stuti Patel Psychologist Medicare: Not Enrolled in Medicare Practice Location: 8311 Roosevelt Rd, Forest Park, IL 60130 Phone: 708-771-7000 |
Bridget Springmire, MA, PSYD Psychologist - Forensic Medicare: Not Enrolled in Medicare Practice Location: 8311 Roosevelt Rd, Forest Park, IL 60130 Phone: 708-209-4181 |
News Archive
When is insurance not really insurance? When you need pricey dental care.
I'm 61 years old and a San Francisco homeowner with an academic position at the University of California-Berkeley, which provides me with comprehensive health insurance. Yet, to afford the more than $50,000 in out-of-pocket expenses required for the restorative dental work I've needed in the past 20 years, I've had to rely on handouts — from my mom.
Shoppers misled by minced meat fat content labelling
Britain's Food Standards Agency has found that shoppers are often being misled by minced meat labels which claim that the product contains less fat than it actually does.
New treatment for lower back pain using patient's own stem cells
A University of Manchester researcher has developed a treatment for lower back pain using the patient's own stem cells, which could replace the use of strong painkillers or surgery that can cause debilitation, neither of which addresses the underlying cause.
Ceregene continues enrollment in new Phase 1/2 clinical study of CERE-120 for Parkinson's disease
Ceregene, Inc., a biopharmaceutical company, announced today that enrollment is proceeding in a new Phase 1/2 clinical study evaluating CERE-120, a gene therapy product which delivers the neurotrophic factor neurturin, to dying neurons in Parkinson's disease patients. This new clinical study follows a completed Phase 2 trial and builds on experience gained in that trial, by enhancing the dosing regimen and optimizing the duration of patient follow up.
Tau PET imaging in Alzheimer's disease increases opportunities for developing effective drugs
Tau PET is a new and promising imaging method for Alzheimer's disease. A case study from Lund University in Sweden now confirms that tau PET images correspond to a higher degree to actual changes in the brain. According to the researchers behind the study, this increases opportunities for developing effective drugs.
› Verified 5 days ago
Counselors
Clinical Social Workers
Occupational Therapists
Dentists
Pharmacists
Psychologists